Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-၀.၂၁%
၁,၀၉၁.၅၁
-၂.၃၀
-၀.၂၁%
—၁,၀၉၃.၈၁၁,၀၉၆.၅၂၁,၁၀၀.၂၂၁,၀၉၁.၅၁——
SIXC
Communications
SIXC
Communications
SIXC
+၀.၂၂%
၆၁၀.၁၁
+၁.၃၄
+၀.၂၂%
—၆၀၈.၇၇၆၀၈.၇၇၆၁၂.၉၇၆၀၈.၇၇——
SIXE
Energy
SIXE
Energy
SIXE
-၁.၃၄%
၁,၂၃၇.၉၈
-၁၆.၈၃
-၁.၃၄%
—၁,၂၅၄.၈၁၁,၂၅၃.၀၁၁,၂၅၃.၈၇၁,၂၂၆.၃၃——
SIXI
Industrials
SIXI
Industrials
SIXI
-၀.၉၃%
၁,၇၄၄.၇၁
-၁၆.၄၀
-၀.၉၃%
—၁,၇၆၁.၁၁၁,၇၆၄.၂၇၁,၇၆၆.၈၈၁,၇၄၄.၇၁——
SIXM
Financials
SIXM
Financials
SIXM
-၀.၃၇%
၆၄၀.၁၈
-၂.၄၀
-၀.၃၇%
—၆၄၂.၅၈၆၄၄.၈၇၆၄၈.၄၈၆၄၀.၁၈——
SIXR
Staples
SIXR
Staples
SIXR
-၀.၁၈%
၈၄၉.၅၈
-၁.၅၅
-၀.၁၈%
—၈၅၁.၁၃၈၅၅.၆၆၈၅၈.၇၅၈၄၅.၅၆——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-၀.၂၃%
၂၁၇.၄၈
-၀.၅၀
-၀.၂၃%
—၂၁၇.၉၈၂၁၇.၉၈၂၁၈.၆၅၂၁၆.၈၈——
SIXT
Technology
SIXT
Technology
SIXT
+၁.၅၂%
၃,၂၆၀.၆၉
+၄၈.၈၆
+၁.၅၂%
—၃,၂၁၁.၈၃၃,၂၂၇.၂၁၃,၂၆၈.၃၈၃,၂၂၆.၅၅——
SIXU
Utilities
SIXU
Utilities
SIXU
-၀.၆၉%
၉၄၂.၄၅
-၆.၅၃
-၀.၆၉%
—၉၄၈.၉၈၉၄၈.၅၈၉၅၇.၈၃၉၄၁.၉၇——
SIXV
Health care
SIXV
Health care
SIXV
-၀.၅၂%
၁,၄၆၆.၈၀
-၇.၇၂
-၀.၅၂%
—၁,၄၇၄.၅၂၁,၄၇၉.၀၃၁,၄၈၁.၀၄၁,၄၆၆.၈၀——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+၀.၂၂%
၂,၃၉၇.၅၀
+၅.၃၈
+၀.၂၂%
—၂,၃၉၂.၁၂၂,၃၉၆.၉၅၂,၄၂၁.၂၂၂,၃၈၂.၃၂——
ROGP:VIE
Roche Holding AG Genussscheine
၃၄၆.၀၀ €
+၁.၁၇%
(+၄.၀၀) 1D
ဧ ၃၀, GMT+၂ ၁၇:၃၆:၀၀  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ROGP...
Open
၃၄၃.၀၀ €
High
၃၄၈.၀၀ €
Low
၃၄၃.၀၀ €
Mkt. cap
ဋေ ၃.၂၈ သ
Avg. vol.
၃.၀၀
Volume
၀.၀၀
52-wk high
၃၅၄.၀၀ €
52-wk low
၃၃၁.၀၀ €
No. of employees
၁ သိန်း
News stories
From sources across the web
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၁ ရက်
Illumina set to report earnings amid rising Roche competition
Stock Titan
Stock Titan
·
ပြီးခဲ့သည့် ၁ ရက်
Vabysmo and Susvimo data lead Genentech's 20 ARVO eye-disease talks
CNBC
CNBC
·
ပြီးခဲ့သည့် ၁ ပတ်
Roche CEO laments Swiss franc strength as drugmaker doubles down on U.S. investment
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76. The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021. F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG Genussscheine
CEOThomas Schinecker
Employees၁.၁၃ သိန်း
Founded၁၈၉၆ အောက် ၁
Headquartersဘေဆဲလ်, Basel City, ဆွစ်ဇာလန်
Sector-
Websiteroche.com
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
၂၀၂၅ မတ်
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
Revenue
ဋေ ၁.၅၉ ထ
ဋေ ၁.၅၉ ထ
ဋေ ၁.၅၈ ထ
ဋေ ၁.၅၈ ထ
Cost of goods sold
၃၈၇.၄၅ ဋေ
၃၈၇.၄၅ ဋေ
၄၂၀.၆၅ ဋေ
၄၂၀.၆၅ ဋေ
Cost of revenue
၃၈၇.၄၅ ဋေ
၃၈၇.၄၅ ဋေ
၄၂၀.၆၅ ဋေ
၄၂၀.၆၅ ဋေ
Research and development expenses
၃၁၁.၃၀ ဋေ
၃၁၁.၃၀ ဋေ
၃၁၅.၄၅ ဋေ
၃၁၅.၄၅ ဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃၂၉.၃၀ ဋေ
၃၂၉.၃၀ ဋေ
၃၅၉.၀၅ ဋေ
၃၅၉.၀၅ ဋေ
Operating expense
၆၂၉.၅၅ ဋေ
၆၂၉.၅၅ ဋေ
၆၈၂.၂၅ ဋေ
၆၈၂.၂၅ ဋေ
Total operating expenses
ဋေ ၁.၀၂ ထ
ဋေ ၁.၀၂ ထ
ဋေ ၁.၁၀ ထ
ဋေ ၁.၁၀ ထ
Operating income
၅၇၅.၄၅ ဋေ
၅၇၅.၄၅ ဋေ
၄၇၂.၄၅ ဋေ
၄၇၂.၄၅ ဋေ
Other non operating income
၄.၀၀ သန်း
၄.၀၀ သန်း
-၁.၅၀ သန်း
-၁.၅၀ သန်း
EBT including unusual items
၄၇၉.၄၀ ဋေ
၄၇၉.၄၀ ဋေ
၃၆၉.၂၅ ဋေ
၃၆၉.၂၅ ဋေ
EBT excluding unusual items
၅၄၆.၄၅ ဋေ
၅၄၆.၄၅ ဋေ
၄၃၇.၃၅ ဋေ
၄၃၇.၃၅ ဋေ
Income tax expense
၈၇.၈၀ ကုဋေ
၈၇.၈၀ ကုဋေ
၇၀.၉၀ ကုဋေ
၇၀.၉၀ ကုဋေ
Effective tax rate
၁၈.၃၁%
၁၈.၃၁%
၁၉.၂၀%
၁၉.၂၀%
Other operating expenses
-၁၁.၀၅ ကုဋေ
-၁၁.၀၅ ကုဋေ
၇.၇၅ ကုဋေ
၇.၇၅ ကုဋေ
Net income
၃၇၀.၅၀ ဋေ
၃၇၀.၅၀ ဋေ
၂၇၃.၅၀ ဋေ
၂၇၃.၅၀ ဋေ
Net profit margin
၂၃.၂၇%
၂၃.၂၇%
၁၇.၃၆%
၁၇.၃၆%
Earnings per share
-
-
-
-
Interest and investment income
၅.၆၅ ကုဋေ
၅.၆၅ ကုဋေ
၄.၅၀ ကုဋေ
၄.၅၀ ကုဋေ
Interest expense
-၃၀.၄၀ ကုဋေ
-၃၀.၄၀ ကုဋေ
-၂၈.၉၅ ကုဋေ
-၂၈.၉၅ ကုဋေ
Net interest expenses
-၂၄.၇၅ ကုဋေ
-၂၄.၇၅ ကုဋေ
-၂၄.၄၅ ကုဋေ
-၂၄.၄၅ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၆၅၂.၅၅ ဋေ
၆၅၂.၅၅ ဋေ
၅၄၉.၆၅ ဋေ
၅၄၉.၆၅ ဋေ
Gain or loss from assets sale
-
-
-၂.၁၅ ကုဋေ
-၂.၁၅ ကုဋေ
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer